EDWARD JENNER INST FOR VACCINE has a total of 16 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, Australia and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CULVER KENNETH WAYNE, BLUM KENNETH and TCM BIOTECH INT CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | Australia | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Mexico | 1 | |
#7 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Tchilian Elma | 4 |
#2 | Beverley Peter | 3 |
#3 | Frith Graeme | 2 |
#4 | Bowness Paul | 2 |
#5 | Stanton Tara | 2 |
#6 | Giuseppina D Agostino | 1 |
#7 | Proietti Enrico | 1 |
#8 | Bodmer Walter | 1 |
#9 | Belardelli Filippo | 1 |
#10 | Schiavoni Giovanna | 1 |
Publication | Filing date | Title |
---|---|---|
GB0723902D0 | Methods for treatment and prevention of infection | |
US2006134614A1 | Screens for altered immune response capability | |
GB0510257D0 | Methods for treatment and prevention of infection | |
GB0307099D0 | Screens for altered immune responses | |
GB0222417D0 | Assay for peptide binding to HLA Class 1 Molecules | |
AU2002304445A1 | Screens for susceptibility to immunodeficiency and viral disease | |
GB0202157D0 | Identifying antigenic molecules | |
GB0114512D0 | Screens for susceptibility to immunodeficiency and viral disease |